McKesson Corporation $MCK Shares Sold by Fox Run Management L.L.C.

Fox Run Management L.L.C. lowered its stake in shares of McKesson Corporation (NYSE:MCK) by 74.5% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 307 shares of the company’s stock after selling 899 shares during the period. Fox Run Management L.L.C.’s holdings in McKesson were worth $237,000 at the end of the most recent reporting period.

Several other institutional investors also recently made changes to their positions in the stock. GGM Financials LLC acquired a new position in McKesson in the third quarter valued at $25,000. State of Wyoming acquired a new position in shares of McKesson in the 2nd quarter valued at about $29,000. Hopwood Financial Services Inc. purchased a new stake in shares of McKesson during the 3rd quarter worth about $31,000. Abound Wealth Management increased its position in McKesson by 104.3% during the 3rd quarter. Abound Wealth Management now owns 47 shares of the company’s stock worth $37,000 after purchasing an additional 24 shares in the last quarter. Finally, Delos Wealth Advisors LLC acquired a new stake in McKesson during the 2nd quarter worth approximately $35,000. 85.07% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have issued reports on MCK shares. Wells Fargo & Company boosted their price objective on shares of McKesson from $914.00 to $925.00 and gave the stock an “equal weight” rating in a research note on Thursday, February 5th. Barclays increased their price target on McKesson from $960.00 to $1,050.00 and gave the company an “overweight” rating in a report on Wednesday, February 18th. Robert W. Baird set a $968.00 target price on McKesson in a research report on Wednesday, January 14th. Morgan Stanley reiterated an “overweight” rating and set a $966.00 target price on shares of McKesson in a report on Thursday, January 29th. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating on shares of McKesson in a research report on Wednesday, December 10th. Thirteen analysts have rated the stock with a Buy rating and four have issued a Hold rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $943.50.

Insider Transactions at McKesson

In other news, EVP Leann B. Smith sold 190 shares of the business’s stock in a transaction that occurred on Tuesday, February 17th. The stock was sold at an average price of $945.00, for a total value of $179,550.00. Following the completion of the sale, the executive vice president directly owned 2,989 shares in the company, valued at approximately $2,824,605. The trade was a 5.98% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, EVP Thomas L. Rodgers sold 276 shares of the firm’s stock in a transaction on Monday, January 5th. The stock was sold at an average price of $816.18, for a total value of $225,265.68. Following the transaction, the executive vice president owned 2,268 shares in the company, valued at $1,851,096.24. This trade represents a 10.85% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 1,143 shares of company stock worth $1,046,070 in the last quarter. Insiders own 0.08% of the company’s stock.

McKesson Stock Up 0.4%

Shares of MCK opened at $995.05 on Wednesday. The firm has a market cap of $121.88 billion, a price-to-earnings ratio of 28.62, a PEG ratio of 1.59 and a beta of 0.38. The business’s 50 day moving average is $875.61 and its two-hundred day moving average is $812.05. McKesson Corporation has a 52-week low of $621.88 and a 52-week high of $999.00.

McKesson (NYSE:MCK) last issued its quarterly earnings results on Wednesday, February 4th. The company reported $9.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $9.19 by $0.15. McKesson had a net margin of 1.09% and a negative return on equity of 338.97%. The business had revenue of $106.16 billion during the quarter, compared to analyst estimates of $105.98 billion. During the same quarter in the previous year, the firm earned $8.03 earnings per share. The business’s revenue was up 11.4% compared to the same quarter last year. McKesson has set its FY 2026 guidance at 38.800-39.200 EPS. On average, equities analysts expect that McKesson Corporation will post 32.77 earnings per share for the current fiscal year.

McKesson Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, April 1st. Shareholders of record on Monday, March 2nd will be paid a dividend of $0.82 per share. The ex-dividend date is Monday, March 2nd. This represents a $3.28 annualized dividend and a yield of 0.3%. McKesson’s dividend payout ratio is presently 9.43%.

About McKesson

McKesson Corporation (NYSE: MCK) is a global healthcare services and distribution company that supplies pharmaceuticals, medical-surgical products and health care technology solutions. Founded in 1833 and headquartered in Irving, Texas, McKesson operates across the drug distribution and healthcare services value chain, connecting manufacturers, pharmacies, hospitals and health systems to help manage the movement of medicines and clinical supplies.

The company’s core activities include pharmaceutical wholesale distribution and logistics, specialty pharmacy services, and the provision of medical-surgical supplies to acute and non-acute care providers.